3j6j
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<SX load='3j6j' size='340' side='right' viewer='molstar' caption='[[3j6j]], [[Resolution|resolution]] 3.64Å' scene=''> | <SX load='3j6j' size='340' side='right' viewer='molstar' caption='[[3j6j]], [[Resolution|resolution]] 3.64Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[3j6j]] is a 8 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3j6j]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3J6J OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3J6J FirstGlance]. <br> |
| - | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">IPS1, KIAA1271, MAVS, VISA ([ | + | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">IPS1, KIAA1271, MAVS, VISA ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3j6j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3j6j OCA], [https://pdbe.org/3j6j PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3j6j RCSB], [https://www.ebi.ac.uk/pdbsum/3j6j PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3j6j ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [[ | + | [[https://www.uniprot.org/uniprot/MAVS_HUMAN MAVS_HUMAN]] Required for innate immune defense against viruses. Acts downstream of DDX58/RIG-I and IFIH1/MDA5, which detect intracellular dsRNA produced during viral replication, to coordinate pathways leading to the activation of NF-kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral cytokines such as IFN-beta and RANTES (CCL5). Peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state. Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response. May activate the same pathways following detection of extracellular dsRNA by TLR3. May protect cells from apoptosis.<ref>PMID:16125763</ref> <ref>PMID:16153868</ref> <ref>PMID:16177806</ref> <ref>PMID:16127453</ref> <ref>PMID:19631370</ref> <ref>PMID:20451243</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Revision as of 03:50, 21 April 2022
3.6 Angstrom resolution MAVS filament generated from helical reconstruction
| |||||||||
Categories: Human | Large Structures | Egelman, E | Hur, S | Li, Z | Peisley, A | Penczek, P | Walz, T | Wu, B | Card | Immune system | Innate immunity | Mav | Mda5 | Rig-i | Seeded filament formation | Spontaneous filament formation
